PREMATURE LUTEINIZATION - TREATMENT AND INCIDENCE IN NATURAL CYCLES

被引:32
作者
CHECK, JH [1 ]
CHASE, JS [1 ]
NOWROOZI, K [1 ]
DIETTERICH, CJ [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,COOPER HOSP UNIV MED CTR,ROBERT WOOD JOHNSON MED SCH,CAMDEN,NJ
关键词
NATURAL CYCLES; PREMATURE LUTEINIZATION; PROGESTERONE;
D O I
10.1093/oxfordjournals.humrep.a137303
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The incidence of premature luteinization was evaluated in 400 women with a history of infertility (greater-than-or-equal-to 18 months). After its diagnosis, this condition was treated with ovulation-inducing drugs in the early follicular phase in an attempt to accelerate follicular maturation before the luteinizing hormone (LH) surge. Premature luteinization was diagnosed if serum progesterone levels > 1.5 ng/ml were associated with an LH surge before the serum oestradiol level reached 200 pg/ml and before the follicle was mature. Fifty-two of 400 (13%) women demonstrated premature luteinization in two consecutive cycles. Fourteen of 52 (27%) women corrected the problem with a clomiphene citrate regimen, as compared with 32 of 38 (75%) treated with HMG and HCG; conception rates were 83 and 50%, respectively, for the patients who responded to the two regimens. Overall, regimens utilized in this study resulted in a 58% pregnancy rate in 6 months.
引用
收藏
页码:190 / 193
页数:4
相关论文
共 11 条
  • [1] Awadalla S.G., Friedman C.I., Chin N.W., Park J.M., Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins, Fertil. Steril, 48, pp. 811-815, (1987)
  • [2] Check J.H., Chase J.H., Ovulation induction in hypergonadotropic amenorrhea with estrogen and human menopausal gonadotropic therapy, Fertil. Steril, 42, pp. 919-922, (1984)
  • [3] Check J.H., Goldberg B.B., Kurtz A., Adelson H.G., Rankin A., Pelvic sonography to help determine the appropriate therapy for luteal phase defects, Int. J. Fertil, 29, (1984)
  • [4] Check J.H., Wu C.H., Dietterich C., Lauer C., Liss J., The treatment of cervical factor with ethinyl estradiol and human menopausal gonadotropins, Int. J. Fertil, 31, (1986)
  • [5] Check J.H., Nowroozi K., Wu C.H., Adelson H.G., Lauer C., Ovulation inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects, Int. J. Fertil, 33, pp. 252-256, (1988)
  • [6] Dodson W.C., Hughes C.L., Whitesides D.R., Haney A.F., The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome, J. Clin. Endocrinol. Metab, 65, pp. 95-100, (1987)
  • [7] Fleming R., Coutts J.R., Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression, Fertil. Steril, 45, pp. 226-230, (1986)
  • [8] Fleming R., Haxton M.J., Hamilton M.P., McCure G.S., Black M.P., Macnaughton M.C., Coutts J.R., Successful treatment of infertile women with oligomenorrhea using a combination of LHRH agonist and exogenous gonadotrophins, Br. J. Obstet. Gynaecol, 92, pp. 369-373, (1985)
  • [9] Goldfarb A.F., Schlaff S., Mansi M.G., A life-table analysis of pregnancy yield in fixed low-dose menotropin therapy for patients in whom clomiphene citrate failed to induce ovulation, Fertil Steril, 37, pp. 639-644, (1982)
  • [10] Hackeloer B.J., Ultrasonic demonstration of follicular development, Lancet, 1, (1978)